Marty Makary
Marty Makary/carey.jhu.edu

Marty Makary Recaps FDA Changes so far Under President Trump’s Leadership

Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X:

“Under President Trump’s leadership, the FDA:
  • Just hit a monthly record cell and gene Tx approvals
  • Hitting ALL drug target date goals
  • Eliminating animal testing requirements
  • Reducing decision times (1 yr to months)
  • Onboarding 1,000 new scientists
  • Accelerating cures, cutting red tape
  • Allowing real world evidence
  • Making decision letters public
  • Incentivizing domestic manufacturing
  • Cutting biosimilar develop costs in half
  • Moving more meds to ‘over the counter’
  • Telling the truth on HRT for women
  • Removing all 9 artificial food dyes
  • Re-writing the broken food pyramid
  • Closing the GRAS loophole
  • Modernizing infant formula
  • New leadership, a new era of innovation
The FDA is strong and will continue to be.”

More posts featuring Marty Makary.